Webdisclosure.fr

EDESA BIOTECH (NASDAQ:EDSA)

20/11/2023 22:05

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

26/10/2023 22:05

Edesa Biotech to Present at Dermatology Drug Development Summit

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

25/10/2023 15:10

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

12/10/2023 18:15

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

12/10/2023 18:10

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

10/10/2023 15:00

Edesa Biotech Announces One-for-Seven Reverse Share Split

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

28/09/2023 14:15

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

09/08/2023 22:15

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

26/07/2023 15:00

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

28/06/2023 13:55

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Voir tous les communiqués de Edesa Biotech

1
2
3
4
5
6
7
8
9
10